Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,507 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endothelial growth factor receptor inhibition after radiotherapy.
Giovannini M, Gregorc V, Viganò MG, Spreafico A, Ghio D, Dell'Oca I, Bolognesi A, Villa E. Giovannini M, et al. J Thorac Oncol. 2007 Jul;2(7):662. doi: 10.1097/JTO.0b013e318074de48. J Thorac Oncol. 2007. PMID: 17607125 Free article. No abstract available.
Antiangiogenic strategies in breast cancer management.
Giovannini M, Aldrighetti D, Zucchinelli P, Belli C, Villa E. Giovannini M, et al. Crit Rev Oncol Hematol. 2010 Oct;76(1):13-35. doi: 10.1016/j.critrevonc.2009.12.004. Epub 2010 Aug 11. Crit Rev Oncol Hematol. 2010. PMID: 20702105 Review.
Will antiangiogenic agents be a future for mesothelioma therapy?
Belli C, Anand S, Panella M, Giovannini M, Tassi G, Fennell D, Mutti L. Belli C, et al. Among authors: giovannini m. Curr Med Chem. 2010;17(27):3069-79. doi: 10.2174/092986710791959710. Curr Med Chem. 2010. PMID: 20629625 Review.
Mammary Paget's disease occurring after mastectomy.
Giovannini M, D'Atri C, Piubello Q, Molino A. Giovannini M, et al. World J Surg Oncol. 2006 Aug 9;4:51. doi: 10.1186/1477-7819-4-51. World J Surg Oncol. 2006. PMID: 16899115 Free PMC article.
Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations.
De Pas T, Toffalorio F, Manzotti M, Fumagalli C, Spitaleri G, Catania C, Delmonte A, Giovannini M, Spaggiari L, de Braud F, Barberis M. De Pas T, et al. Among authors: giovannini m. J Thorac Oncol. 2011 Nov;6(11):1895-901. doi: 10.1097/JTO.0b013e318227e8c6. J Thorac Oncol. 2011. PMID: 21841502 Free article.
1,507 results